ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines

Publisher： Karger

E-ISSN： 1423-0194|91|2|121-130

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.91, Iss.2, 2009-11, pp. : 121-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Novel mTOR Inhibitor RAD001 (Everolimus) Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 85, Iss. 1, 2007-02 ,pp. : 54-60

Karger

Access to resources Recommend Favorite

Nuclear Survivin Is a Powerful Novel Prognostic Marker in Gastroenteropancreatic Neuroendocrine Tumor Disease

By  

Neuroendocrinology, Vol. 81, Iss. 1, 2005-05 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease

By  

Neuroendocrinology, Vol. 105, Iss. 1, 2016-08 ,pp. : 90-104

Karger

Access to resources Recommend Favorite

Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor

By  

Neuroendocrinology, Vol. 103, Iss. 5, 2015-08 ,pp. : 452-459

Karger

Access to resources Recommend Favorite

Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2015-12 ,pp. : 724-737

Karger

Access to resources Recommend Favorite